Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker CVKD
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Quang X. Pham Chairman and CEO, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 7,400 | $3.03 | $22.4K Sale | Form 4 ↗ |
| Jun 26, 2026 | Quang X. Pham Chairman, CEO and Interim CFO, Director… | CVKD Cadrenal Therapeutics, Inc. | Sale | 9,029 | $3.05 | $27.5K Sale | Form 4 ↗ |
| Jun 25, 2026 | Quang X. Pham Chairman, CEO and Interim CFO, Director… | CVKD Cadrenal Therapeutics, Inc. | Sale | 2,127 | $3.00 | $6,381 Sale | Form 4 ↗ |
| Jun 23, 2026 | Quang X. Pham Chairman, CEO and Interim CFO, Director… | CVKD Cadrenal Therapeutics, Inc. | Sale | 2,277 | $3.20 | $7,286 Sale | Form 4 ↗ |
| Jun 22, 2026 | Quang X. Pham Chairman, CEO and Interim CFO, Director… | CVKD Cadrenal Therapeutics, Inc. | Sale | 9,167 | $3.55 | $32.5K Sale | Form 4 ↗ |
| Jun 17, 2026 | Quang X. Pham Chairman, CEO and Interim CFO, Director… | CVKD Cadrenal Therapeutics, Inc. | Sale | 513 | $3.16 | $1,621 Sale | Form 4 ↗ |
| Jun 16, 2026 | Quang X. Pham Chairman, CEO and Interim CFO, Director… | CVKD Cadrenal Therapeutics, Inc. | Sale | 3,613 | $3.18 | $11.5K Sale | Form 4 ↗ |
| Jun 15, 2026 | Quang X. Pham Chairman, CEO and Interim CFO, Director… | CVKD Cadrenal Therapeutics, Inc. | Sale | 3,666 | $3.58 | $13.1K Sale | Form 4 ↗ |
| Jun 12, 2026 | Quang X. Pham Chairman, CEO and Interim CFO, Director… | CVKD Cadrenal Therapeutics, Inc. | Sale | 12,996 | $3.94 | $51.2K Sale | Form 4 ↗ |
| Jun 11, 2026 | Quang X. Pham Chairman, CEO and Interim CFO, Director… | CVKD Cadrenal Therapeutics, Inc. | Sale | 1,462 | $4.12 | $6,023 Sale | Form 4 ↗ |
| Jun 10, 2026 | Quang X. Pham Chairman, CEO and Interim CFO, Director… | CVKD Cadrenal Therapeutics, Inc. | Sale | 3,500 | $4.21 | $14.7K Sale | Form 4 ↗ |
| Jun 9, 2026 | Quang X. Pham Chairman, CEO and Interim CFO, Director… | CVKD Cadrenal Therapeutics, Inc. | Sale | 12,992 | $4.06 | $52.7K Sale | Form 4 ↗ |
| Jun 8, 2026 | Quang X. Pham Chairman, CEO and Interim CFO, Director… | CVKD Cadrenal Therapeutics, Inc. | Sale | 5,893 | $4.38 | $25.8K Sale | Form 4 ↗ |
| Jun 5, 2026 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 2,064 | $4.42 | $9,123 Sale | Form 4 ↗ |
| Jun 4, 2026 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 3,898 | $4.41 | $17.2K Sale | Form 4 ↗ |
| Jun 3, 2026 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 2,323 | $4.26 | $9,896 Sale | Form 4 ↗ |
| Jun 2, 2026 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 349 | $4.46 | $1,557 Sale | Form 4 ↗ |
| May 29, 2026 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 303 | $5.01 | $1,518 Sale | Form 4 ↗ |
| May 28, 2026 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 2,989 | $4.93 | $14.7K Sale | Form 4 ↗ |
| May 22, 2026 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 1,165 | $5.69 | $6,629 Sale | Form 4 ↗ |
| May 12, 2026 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 3,298 | $5.28 | $17.4K Sale | Form 4 ↗ |
| May 11, 2026 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 6,476 | $5.76 | $37.3K Sale | Form 4 ↗ |
| Dec 29, 2025 | Matthew K. Szot Chief Financial Officer | CVKD Cadrenal Therapeutics, Inc. | Sale | 9,933 | $6.97 | $69.2K Sale | Form 4 ↗ |
| Oct 27, 2025 | Matthew K. Szot Chief Financial Officer | CVKD Cadrenal Therapeutics, Inc. | Sale | 1,800 | $13.99 | $25.2K Sale | Form 4 ↗ |
| Oct 27, 2025 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 1,315 | $13.99 | $18.4K Sale | Form 4 ↗ |
| Oct 24, 2025 | Matthew K. Szot Chief Financial Officer | CVKD Cadrenal Therapeutics, Inc. | Sale | 1,800 | $13.99 | $25.2K Sale | Form 4 ↗ |
| Oct 24, 2025 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 1,129 | $14.03 | $15.8K Sale | Form 4 ↗ |
| Oct 13, 2025 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 1,800 | $14.15 | $25.5K Sale | Form 4 ↗ |
| Oct 13, 2025 | Matthew K. Szot Chief Financial Officer | CVKD Cadrenal Therapeutics, Inc. | Sale | 1,800 | $14.07 | $25.3K Sale | Form 4 ↗ |
| Oct 9, 2025 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 1,800 | $14.02 | $25.2K Sale | Form 4 ↗ |
| Oct 9, 2025 | Matthew K. Szot Chief Financial Officer | CVKD Cadrenal Therapeutics, Inc. | Sale | 1,693 | $13.99 | $23.7K Sale | Form 4 ↗ |
| Oct 6, 2025 | Matthew K. Szot Chief Financial Officer | CVKD Cadrenal Therapeutics, Inc. | Sale | 107 | $13.99 | $1,497 Sale | Form 4 ↗ |
| Oct 2, 2025 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 500 | $14.13 | $7,065 Sale | Form 4 ↗ |
| Oct 1, 2025 | Matthew K. Szot Chief Financial Officer | CVKD Cadrenal Therapeutics, Inc. | Sale | 1,700 | $13.99 | $23.8K Sale | Form 4 ↗ |
| Oct 1, 2025 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 881 | $14.01 | $12.3K Sale | Form 4 ↗ |
| Sep 29, 2025 | Matthew K. Szot Chief Financial Officer | CVKD Cadrenal Therapeutics, Inc. | Sale | 100 | $14.00 | $1,400 Sale | Form 4 ↗ |
| Sep 29, 2025 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 419 | $14.01 | $5,870 Sale | Form 4 ↗ |
| Sep 25, 2025 | Matthew K. Szot Chief Financial Officer | CVKD Cadrenal Therapeutics, Inc. | Sale | 10,900 | $14.05 | $153.1K Sale | Form 4 ↗ |
| Sep 25, 2025 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 6,790 | $14.09 | $95.7K Sale | Form 4 ↗ |
| Sep 24, 2025 | Matthew K. Szot Chief Financial Officer | CVKD Cadrenal Therapeutics, Inc. | Sale | 1,500 | $14.00 | $21.0K Sale | Form 4 ↗ |
| Sep 24, 2025 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 2,581 | $13.99 | $36.1K Sale | Form 4 ↗ |
| Aug 28, 2025 | Matthew K. Szot Chief Financial Officer | CVKD Cadrenal Therapeutics, Inc. | Sale | 400 | $14.00 | $5,600 Sale | Form 4 ↗ |
| Aug 28, 2025 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 1,193 | $13.99 | $16.7K Sale | Form 4 ↗ |
| Aug 27, 2025 | Matthew K. Szot Chief Financial Officer | CVKD Cadrenal Therapeutics, Inc. | Sale | 1,600 | $14.00 | $22.4K Sale | Form 4 ↗ |
| Aug 27, 2025 | Quang X. Pham CEO and Chairman, Director, 10% owner | CVKD Cadrenal Therapeutics, Inc. | Sale | 3,836 | $13.99 | $53.7K Sale | Form 4 ↗ |
45 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:48 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances